New drug tested in kids to control kidney disease complications
Disease control
Not yet recruiting
This study is testing an extended-release capsule called CTAP101 in children under 18 who have chronic kidney disease, a related hormone imbalance, and low vitamin D. The main goals are to see how the drug moves through the body, how it works, and if it is safe and tolerable. Abo…
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC